Onco-LIFE™ Autofluorescence System
Onco-LIFE™ is indicated for use with fluorescence imaging during bronchoscopy as an adjunct to white light imaging, to detect and localize tissue suspicious for moderate or severe dysplasia, carcinoma in situ, or invasive cancer in patients with suspected or previously treated lung cancer.
IMPROVED SENSITIVITY
325% per-lesion improvement in the detection of moderate to severe dysplasia and carcinoma in situ over white light endoscopy alone*
250% per-patient improvement in the detection of moderate to severe dysplasia and carcinoma in situ over white light endoscopy alone*
SIMPLICITY
Toggle between fluorescence and white light imaging with the press of a button
Picture-in-picture capability to display fluorescence and white light images simultaneously
Real-time, high resolution images in both imaging modes
Numeric display of red/green color ratio
VERSATILITY
Compatible with a wide rage of fiberoptic endoscopes
* Summary of safety and effectiveness data (PMA supplement to P950042/S003, 28 June 2005)
|